Authors’ reply: the biologic importance of the vitamin D binding protein polymorphism in pediatric COVID-19 patients


BAYRAMOĞLU E., Akkoç G., AĞBAŞ A., Akgün Ö., Yurdakul K., Duru H. N. S., ...Daha Fazla

European Journal of Pediatrics, cilt.180, sa.8, ss.2709-2710, 2021 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Kısa Makale
  • Cilt numarası: 180 Sayı: 8
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1007/s00431-021-04109-9
  • Dergi Adı: European Journal of Pediatrics
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.2709-2710
  • Anahtar Kelimeler: COVID-19, Vitamin D, Vitamin D binding protein
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

What is Known?• Vitamin D has multiple roles in the immune system that can modulate the body reaction to an infection• Vitamin D binding protein (DBP) is the key transport protein which, along with albumin, binds over 99% of the circulating vitamin D metabolitesWhat is New?• Lower 25 OH vitamin D levels were associated with higher inflammation markers, suggesting an important role of vitamin D in the clinical course of COVID-19 in children and adolescents probably by regulating the systemic inflammatory response• Further studies are warranted to investigate the possible causal association of DBP levels and polymorphism with vitamin D status (total and bioavailable vitamin D) in COVID-19 patients.